Tony Hollenberg, MD, John Wade Professor and Chair of the Department of Medicine, has been appointed President of Boston Medical Center
As we continue to reimagine how we deliver expert and equitable care to our patients and members as a fully integrated health system, we are excited to share that the BMC Board of Directors has voted to appoint Anthony “Tony” Hollenberg, MD, as President of Boston Medical Center. Dr. Hollenberg was selected following an extensive national search and currently serves as Physician-in-Chief at Boston Medical Center and the John Wade Professor and Chair of the Department of Medicine at Boston University Chobanian & Avedisian School of Medicine. He will assume the role of hospital President on June 3.
Dr. Hollenberg’s deep leadership experience at academic medical centers, demonstrated experience as a highly accomplished physician-researcher, and longstanding commitment to clinical excellence and health equity make him an ideal leader to lead Boston Medical Center as we bolster our reputation as a premier academic medical center. In this role, Dr. Hollenberg will provide strategic leadership across our hospital to further our delivery against institutional goals, advance a culture of high-quality patient care, and elevate our research endeavors.
Throughout his time leading the Department of Medicine — the largest clinical department at BMC — Dr. Hollenberg has partnered with colleagues from across the organization to drive healthier outcomes for our patients and communities by incorporating advancements in cutting-edge clinical practices, including innovative CAR T-cell therapies for cancer and gene therapies for patients living with sickle cell disease. Additionally, he has supported novel research that addresses the unmet medical needs of our patients and the broader communities we serve. Prior to joining BMC and BU, Dr. Hollenberg was the Chair of the Joan and Sanford I. Weill Department of Medicine at Weill Cornell Medicine and Physician-in-Chief at NewYork-Presbyterian/Weill Cornell Medical Center in New York City. He also previously served as Chief of the Division of Endocrinology, Diabetes, and Metabolism and Vice Chair for Mentoring at Beth Israel Deaconess Medical Center and Professor of Medicine at Harvard Medical School.
As a specialist in endocrinology, Dr. Hollenberg’s clinical work focuses on thyroid disorders, and his research has centered on investigating the physiological and molecular mechanisms by which thyroid hormones regulate metabolism, including body weight, as well as thyroid gland development. He has published more than 100 original studies in journals and contributed more than 30 book chapters and reviews.
Dr. Hollenberg, a native of Toronto, received his bachelor’s degree from Harvard College and his medical degree from the University of Calgary. He completed his residency in Internal Medicine at Beth Israel Deaconess Medical Center, followed by a clinical and research fellowship at Massachusetts General Hospital.
Karen Antman, MD, BUMC Provost and Dean, BU Chobanian & Avedisian School of Medicine, and I are grateful to Dr. Hollenberg for advancing the Department of Medicine since 2022. Dr. Hollenberg joins Heather Thiltgen, President of WellSense Health Plan, and Nicole Faucher, President of Clearway Health, as a leader of our health system’s largest entities.
We will be launching a search for a Chief and Chair to continue to advance the Department of Medicine’s rich history of clinical innovation. We are pleased to share that Sushrut Waikar, MD, Chief of Nephrology, will serve in an interim capacity and be supported by Dr. Hollenberg. Please join us in thanking Dr. Waikar for stepping into an interim leadership role.
Please also join us in congratulating Dr. Hollenberg on his new role as hospital President.